Key interventions to undertake to increase survival for breast cancer patients are: improving capacity to meet patient-volume demands for pathology and hormone receptor testing, developing pathways for complete surgical staging (additional imaging, lymph node evaluation), and providing access to/ensuring completion of prescribed adjuvant chemotherapies. This evidence concerns the gene NR4A1 and breast carcinoma.